[Has the clinical trials in Japan been accepted by the society?].
作者信息
Saijo S, Yoshida S
机构信息
Pharmacology Division, National Cancer Center Research Institute, Japan.
出版信息
Gan To Kagaku Ryoho. 1996 Jan;23(2):129-35.
PMID:8611038
Abstract
The difference between clinical trial and clinical practice of cancer treatment were discussed. The problems of clinical trials in Japan was clarified. The conditions how clinical can be accepted by the society were discussed.
摘要
相似文献
1
[Has the clinical trials in Japan been accepted by the society?].
Gan To Kagaku Ryoho. 1996 Jan;23(2):129-35.
2
[Problems in conducting clinical trials for cancer patients].[癌症患者临床试验实施中的问题]
Gan To Kagaku Ryoho. 1996 Jan;23(2):151-5.
3
[Current issues and perspectives in Japan Clinical Oncology Group].[日本临床肿瘤学会的当前问题与观点]
Gan To Kagaku Ryoho. 1999 Jan;26(2 Suppl):204-11.
4
[Huriet's law in cancerology. Public opinion on informed consent].[肿瘤学中的于里埃定律。关于知情同意的公众意见]
Bull Cancer. 1993 Oct;80(10):882-4.
5
[The guideline for clinical trials proposed by Japan Society for Cancer Therapy (JSCT)].
Gan To Kagaku Ryoho. 1996 Jan;23(2):156-65.
6
[Getting informed consent in clinical trials on Japanese cancer patients].[在针对日本癌症患者的临床试验中获取知情同意书]
Gan To Kagaku Ryoho. 1996 Jan;23(2):146-50.
7
[The importance of scientific clinical trials].[科学临床试验的重要性]
Gan To Kagaku Ryoho. 1996 Jan;23(2):136-40.
8
[The present status and prospects for clinical oncology in Japan].[日本临床肿瘤学的现状与展望]
Gan To Kagaku Ryoho. 1994 Oct;21 Suppl 3:281-8.
9
[Globalization of clinical trials].[临床试验的全球化]
Gan To Kagaku Ryoho. 2003 Apr;30(4):555-65.
10
[The role of the Japan Clinical Oncology Group].[日本临床肿瘤学会的作用]
Gan To Kagaku Ryoho. 2000 Jul;27(8):1127-32.
Zotero 插件